Logo do repositório
 
Publicação

Do MAFLD patients with harmful alcohol consumption have a different dietary intake?

dc.contributor.authorPolicarpo, Sara
dc.contributor.authorCarvalhana, Sofia
dc.contributor.authorCraciun, Ana
dc.contributor.authorCrespo, Ricardo Rios
dc.contributor.authorCortez-Pinto, Helena
dc.date.accessioned2022-11-04T16:36:17Z
dc.date.available2022-11-04T16:36:17Z
dc.date.issued2022
dc.description© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).pt_PT
dc.description.abstractThe term metabolic-associated fatty liver disease (MAFLD) has been proposed to define positively fatty liver disease in the form associated with metabolic risk factors. The aim of this study was to assess the dietary intake of MAFLD and explore a possible relationship between its inflammatory characteristics (assessed by Dietary Inflammatory Index-DII®), the degree of liver fibrosis (assessed by transient elastography), and the amount of alcohol intake. MAFLD patients were included (n = 161) and were classified, according to the amount of alcoholic intake, as MAFLD without alcohol intake (n = 77) and MAFLD with alcohol intake (n = 84), with 19 presenting harmful alcoholic consumption. Dietary intake was 1868 ± 415 kcal/day and did not present differences in energy or nutrient intake based on the presence of metabolic comorbidities. Patients with MAFLD and alcohol intake consumed significantly more energy and presented a tendency for higher intake of carbohydrates and sugar. Patients with harmful alcohol intake presented a higher intake of total fat and cholesterol compared with moderate alcohol intake. There were no differences in DII® based on fibrosis severity or the amount of alcohol consumption. This work contributes to the characterization of baseline dietary intake in MAFLD patients, paving the way to design more suited dietary interventional trials.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationNutrients. 2022 Mar 23;14(7):1335pt_PT
dc.identifier.doi10.3390/nu14071335pt_PT
dc.identifier.eissn2072-6643
dc.identifier.urihttp://hdl.handle.net/10451/54961
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherMDPIpt_PT
dc.relation.publisherversionhttps://www.mdpi.com/journal/nutrientspt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectAdvanced fibrosispt_PT
dc.subjectDietary inflammatory indexpt_PT
dc.subjectFatpt_PT
dc.subjectSteatosispt_PT
dc.subjectSugarpt_PT
dc.titleDo MAFLD patients with harmful alcohol consumption have a different dietary intake?pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue7pt_PT
oaire.citation.titleNutrientspt_PT
oaire.citation.volume14pt_PT
person.familyNamePolicarpo
person.familyNamecarvalhana
person.familyNameCraciun
person.familyNameCrespo
person.familyNameCortez-Pinto
person.givenNameSara
person.givenNamesofia
person.givenNameAna
person.givenNameRicardo
person.givenNameHelena
person.identifier.ciencia-id841C-E5A8-46C4
person.identifier.ciencia-idA01C-0511-C986
person.identifier.orcid0000-0001-8594-1720
person.identifier.orcid0000-0001-6120-2333
person.identifier.orcid0000-0001-9778-3686
person.identifier.orcid0000-0002-2424-4961
person.identifier.orcid0000-0002-8537-8744
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication18ef9bc3-1f7a-414b-b2aa-a1163f2f2367
relation.isAuthorOfPublicationcb236618-84cf-4c42-a22f-3d6d0521e768
relation.isAuthorOfPublication46639b3c-37b8-4aba-ad28-e0cb21e14b34
relation.isAuthorOfPublicationffa825ce-1c16-4aff-8e28-e3f6acfc569b
relation.isAuthorOfPublication91fdb4b3-d491-4e67-94ff-dcf5013fa1a7
relation.isAuthorOfPublication.latestForDiscoveryffa825ce-1c16-4aff-8e28-e3f6acfc569b

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
MAFLD.pdf
Tamanho:
657.52 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: